1180181

Lilly France S.A.S. — FEI 3002807475

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 15, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fegersheim (France)

Additional Details

Mutual Recognition Agreement (MRA)